International Stem Cell Corporation (OTCBB:ISCOE) said today that chairman Kenneth Aldrich, will present at the Lippert/Heilshorn & Associates Life Sciences & Medical Technologies Virtual Conference this week.
The presentation will be held on Thursday, June 16, at 10:30am EST. A webcast will be accessible online at www.internationalstemcell.com, with an archived version to be available for 30 days.
The company is focused on the therapeutic applications of human parthenogenetic stem cells, which are created from unfertilized eggs, avoiding ethical issues associated with the destruction of viable human embroys. These cells can be used to cure a host of diseases, and have minimal immune rejection.
International Stem Cell also uses its proprietary technology for the development and commercialization of cell-based research and cosmetic products.
Proactiveinvestors is a leading multi-media news organisation, investor portal and events management business with offices in New York, Sydney, Toronto, Frankfurt and London.
No comments:
Post a Comment